Clinical trial
An Open-Label Prospective Cohort Study of JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo
NCT02977715 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Prospective Cohort Study of JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 23, 2017
- Completion date
- October 31, 2025
- Enrollment
- 1,600 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
monkeypox virus infection